1. Home
  2. ARMP vs III Comparison

ARMP vs III Comparison

Compare ARMP & III Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Armata Pharmaceuticals Inc.

ARMP

Armata Pharmaceuticals Inc.

HOLD

Current Price

$3.66

Market Cap

199.7M

Sector

Health Care

ML Signal

HOLD

Logo Information Services Group Inc.

III

Information Services Group Inc.

HOLD

Current Price

$6.18

Market Cap

197.1M

ML Signal

HOLD

Company Overview

Basic Information
Metric
ARMP
III
Founded
N/A
2006
Country
United States
United States
Employees
N/A
1500
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Professional Services
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
199.7M
197.1M
IPO Year
1996
2006

Fundamental Metrics

Financial Performance
Metric
ARMP
III
Price
$3.66
$6.18
Analyst Decision
Strong Buy
Buy
Analyst Count
2
2
Target Price
★ $17.50
$6.80
AVG Volume (30 Days)
96.2K
★ 222.1K
Earning Date
11-11-2026
11-02-2026
Dividend Yield
N/A
★ 2.92%
EPS Growth
N/A
★ 216.67
EPS
N/A
★ 0.12
Revenue
N/A
★ $192,745,000.00
Revenue This Year
N/A
$4.24
Revenue Next Year
N/A
$3.59
P/E Ratio
★ N/A
$51.50
Revenue Growth
N/A
★ 4.51
52 Week Low
$2.75
$3.74
52 Week High
$14.98
$6.45

Technical Indicators

Market Signals
Indicator
ARMP
III
Relative Strength Index (RSI) 49.63 73.47
Support Level $3.38 $3.86
Resistance Level $4.07 N/A
Average True Range (ATR) 0.36 0.18
MACD 0.07 0.02
Stochastic Oscillator 69.06 92.59

Price Performance

Historical Comparison
ARMP
III

About ARMP Armata Pharmaceuticals Inc.

Armata Pharmaceuticals Inc is a late clinical-stage biotechnology company focused on the development of high-purity and potent, pathogen-specific bacteriophage therapeutics for the treatment of antibiotic-resistant and difficult-to-treat bacterial infections using proprietary bacteriophage-based technology. It has completed three Phase 2 clinical trials to date. The Company operates and manages its business as one reportable operating segment, which is the business of developing pathogen-specific bacteriophage therapeutics for the treatment of antibiotic-resistant and difficult-to-treat acute and chronic bacterial infections using its proprietary bacteriophage-based technology.

About III Information Services Group Inc.

Information Services Group Inc is an AI-centered technology research and advisory firm providing digital transformation and technology advisory services that help organizations optimize performance, reduce costs, and accelerate innovation. The Company's expertise includes sourcing advisory, cloud and data analytics, managed governance and risk services, network and software advisory, technology strategy and operations design, change management, and market intelligence, serving both private- and public-sector clients globally. It operates in one segment, fact-based sourcing advisory services, and operates principally in the Americas, with generate maximum revenue in Europe and the Asia Pacific.

Share on Social Networks: